Ally Financial Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ally Financial Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.91B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $8.18B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $8.23B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $8.43B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $8.21B | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $1.98B | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | $1.68B | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | $1.61B | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | $1.41B | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $1.64B | Feb 24, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.20B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $968.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $908.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $852.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $753.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $727.00M | Feb 25, 2022 |
| FY2019 | Dec 31, 2018 | $689.00M | Feb 25, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.47B | Feb 21, 2018 |
| FY2017 | Sep 30, 2017 | $1.46B | Feb 21, 2018 |
| FY2017 | Jun 30, 2017 | $1.46B | Feb 21, 2018 |
| FY2017 | Mar 31, 2017 | $1.38B | Feb 21, 2018 |
| FY2016 | Dec 31, 2016 | $1.37B | Feb 27, 2017 |
| FY2016 | Sep 30, 2016 | $1.38B | Feb 27, 2017 |
| FY2016 | Jun 30, 2016 | $1.36B | Feb 27, 2017 |
| FY2016 | Mar 31, 2016 | $1.33B | Feb 27, 2017 |
| FY2016 | Dec 31, 2015 | $1.34B | Feb 27, 2017 |
| FY2016 | Sep 30, 2015 | $1.30B | Feb 27, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $852.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | $108.00M | Feb 19, 2025 |
| FY2024 | Sep 30, 2024 | $198.00M | Feb 19, 2025 |
| FY2024 | Jun 30, 2024 | $219.00M | Feb 19, 2025 |
| FY2024 | Mar 31, 2024 | $143.00M | Feb 19, 2025 |
| FY2024 | Dec 31, 2023 | $62.00M | Feb 19, 2025 |
| FY2024 | Sep 30, 2023 | $285.00M | Feb 19, 2025 |
| FY2024 | Jun 30, 2023 | $311.00M | Feb 19, 2025 |
| FY2024 | Mar 31, 2023 | $299.00M | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $1.71B | Feb 19, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.73B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.53B | Feb 25, 2026 |
| FY2024 | Sep 30, 2024 | $3.58B | Feb 19, 2025 |
| FY2024 | Jun 30, 2024 | $2.72B | Feb 19, 2025 |
| FY2024 | Mar 31, 2024 | $1.27B | Feb 19, 2025 |
| FY2025 | Dec 31, 2023 | $4.56B | Feb 25, 2026 |
| FY2024 | Sep 30, 2023 | $4.61B | Feb 19, 2025 |
| FY2024 | Jun 30, 2023 | $2.98B | Feb 19, 2025 |
| FY2024 | Mar 31, 2023 | $1.41B | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $6.25B | Feb 19, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $196.00B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $191.84B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $196.33B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $191.83B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $182.11B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $182.17B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $180.64B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $178.87B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $167.15B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $163.73B | Feb 20, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $180.50B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $177.93B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $182.63B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $178.97B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $165.06B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $167.46B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $166.23B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $165.60B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $153.65B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $150.41B | Feb 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.50B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $13.90B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $13.70B | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $12.86B | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $17.05B | Feb 19, 2025 |
| FY2023 | Dec 31, 2020 | $14.70B | Feb 20, 2024 |
| FY2022 | Dec 31, 2019 | $14.42B | Feb 24, 2023 |
| FY2019 | Jan 1, 2019 | $13.27B | Feb 25, 2020 |
| FY2021 | Dec 31, 2018 | $13.27B | Feb 25, 2022 |
| FY2019 | Jan 1, 2018 | $13.38B | Feb 25, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $190.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $551.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $669.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $822.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $822.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $343.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $393.00M | Feb 25, 2022 |
| FY2019 | Dec 31, 2018 | $240.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $240.00M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $240.00M | Feb 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $633.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $270.00M | Feb 25, 2026 |
| FY2024 | Sep 30, 2024 | $284.00M | Feb 19, 2025 |
| FY2024 | Jun 30, 2024 | $208.00M | Feb 19, 2025 |
| FY2024 | Mar 31, 2024 | $111.00M | Feb 19, 2025 |
| FY2024 | Dec 31, 2023 | $91.00M | Feb 19, 2025 |
| FY2024 | Sep 30, 2023 | $148.00M | Feb 19, 2025 |
| FY2024 | Jun 30, 2023 | ($15.00M) | Feb 19, 2025 |
| FY2024 | Mar 31, 2023 | ($205.00M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | ($384.00M) | Feb 20, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.03B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $10.29B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $6.95B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $5.57B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $5.06B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $15.62B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $3.56B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $4.54B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $4.25B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $5.93B | Feb 21, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.07B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $17.50B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $17.57B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $17.76B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $17.03B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $22.01B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $34.03B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $44.19B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $44.23B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $54.13B | Feb 21, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Feb 19, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Feb 19, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Feb 19, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Feb 19, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Feb 19, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Feb 19, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Feb 19, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | 5 | Feb 19, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 25, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Feb 19, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Feb 19, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Feb 19, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Feb 19, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Feb 19, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Feb 19, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Feb 19, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | 5 | Feb 19, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 308.49M | Feb 25, 2026 |
| FY2025 | Sep 30, 2025 | 307.83M | Feb 25, 2026 |
| FY2025 | Jun 30, 2025 | 307.79M | Feb 25, 2026 |
| FY2025 | Mar 31, 2025 | 307.15M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 305.39M | Feb 25, 2026 |
| FY2025 | Sep 30, 2024 | 304.72M | Feb 25, 2026 |
| FY2025 | Jun 30, 2024 | 304.66M | Feb 25, 2026 |
| FY2025 | Mar 31, 2024 | 303.98M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 302.46M | Feb 25, 2026 |
| FY2024 | Sep 30, 2023 | 301.63M | Feb 19, 2025 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $379.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $372.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $368.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $384.00M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $324.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $289.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $273.00M | Feb 25, 2022 |